E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers Tenders > Headlines for 2013 > News item
Published on 3/1/2013 in the Prospect News Emerging Markets Daily, Prospect News Investment Grade Daily and Prospect News Liability Management Daily.

Israel's Teva Pharmaceutical calls $500 million 5.55% notes due 2016

By Tali David

Minneapolis, March 1 - Teva Pharmaceutical Industries Ltd. finance subsidiary Teva Pharmaceutical Finance Co., LLC called its roughly $500 million of 5.55% senior notes due 2016, according to a press release.

The notes will be redeemed at par plus a make-whole premium and accrued interest from Feb. 1 on March 22.

The redemption is being funded with cash on hand.

Teva is a Petach Tikva, Israel-based pharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.